This NDC is on FDA's drug shortage list (posted Jan 11, 2024)

Reported reason: Shortage of an active ingredient

Product Information

LISDEXAMFETAMINE 70 MG CAPSULE is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $2.6051 per EA under NDC 42858016701. Its NADAC has been published 134 times since Apr 24, 2024.

FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 70 MG CAPSULE

LISDEXAMFETAMINE DIMESYLATE
$2.6051per EA
DEA Schedule CII

Strength

70 mg/1

NDC

42858016701

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215330

FDA Approved

8/25/2023

TE Code

AB

On Market Since

1/30/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 70 MG CAPSULE has been published 134 times since Apr 24, 2024, and over the history we have for it it has declined 63.6%. The table below summarizes its recorded NADAC range and movement.

Current price$2.6051 per EA
All-time high$7.1540 (May 15, 2024)
All-time low$2.6051 (Oct 21, 2026)
52-week high$3.1787
52-week low$2.6051
Median price$3.6848
Average price$4.1470
Largest weekly change+66.2% (Aug 21, 2024)
Weeks tracked134
Tracking sinceApr 24, 2024

Price History

1W

0.0%

1M

-2.6%

3M

-7.3%

6M

-11.2%

1Y

-19.8%

3Y

N/A

5Y

N/A

All

-63.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 70 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 70 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $2.6051 per EA (NDC 42858016701), effective Nov 11, 2026.

How has the price of LISDEXAMFETAMINE 70 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 70 MG CAPSULE has declined 63.6%. It has been tracked across 134 weekly CMS publications since Apr 24, 2024.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 70 MG CAPSULE?

Since Apr 24, 2024, the NADAC for LISDEXAMFETAMINE 70 MG CAPSULE has ranged from a low of $2.6051 (Oct 21, 2026) to a high of $7.1540 (May 15, 2024), with a median of $3.6848 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 70 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 70 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures LISDEXAMFETAMINE 70 MG CAPSULE?

LISDEXAMFETAMINE 70 MG CAPSULE (NDC 42858016701) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.

Is LISDEXAMFETAMINE 70 MG CAPSULE in shortage?

Yes — NDC 42858016701 is currently listed in FDA's drug shortage database (posted Jan 11, 2024). Reported reason: Shortage of an active ingredient.